P42166 (LAP2A_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 142.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Lamina-associated polypeptide 2, isoform alpha Alternative name(s): Thymopoietin isoform alpha Short name=TP alpha Thymopoietin-related peptide isoform alpha Short name=TPRP isoform alpha Cleaved into the following 2 chains:
| ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 694 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. Plays an important role, together with LMNA, in the nuclear anchorage of RB1. TP and TP5 may play a role in T-cell development and function. TP5 is an immunomodulating pentapeptide. |
| Subunit structure | Interacts with LMNA, BANF1 and RB1 and with chromosomes. Associates directly or indirectly with lamins at specific cell-cycle stages. Ref.7 Ref.8 Ref.9 |
| Subcellular location | Nucleus. Chromosome. Note: Expressed diffusely throughout the nucleus. |
| Tissue specificity | Expressed in many tissues. Most abundant in adult thymus and fetal liver. |
| Domain | The N-terminal part contains two structurally independent, non-interacting domains: LEM-like (also called LAP2-N or LEM-D) and LEM (also called LAP2-C or LEM-B). LEM-like binds DNA while LEM interacts with BANF1. The C-terminal domain forms a four-stranded coiled coil By similarity. |
| Post-translational modification | Phosphorylated in a mitose-specific manner. Ref.7 |
| Involvement in disease | Cardiomyopathy, dilated 1T (CMD1T) [MIM:613740]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. |
| Pharmaceutical use | TP5 is available under the names Timunox (Cilag), Sintomodulina (Italofarmaco) and Mepentil (Recordati). Used in primary and secondary immune deficiencies, autoimmunity, infections and cancer. |
| Sequence similarities | Belongs to the LEM family. Contains 1 LEM domain. Contains 1 LEM-like domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Chromosome Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Cardiomyopathy Disease mutation |
| Domain | Coiled coil |
| Ligand | DNA-binding |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Pharmaceutical Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | regulation of transcription, DNA-dependent Inferred from electronic annotation. Source: Compara |
| Cellular_component | chromatin Inferred from direct assay PubMed 17284516. Source: MGI nuclear envelopeTraceable author statement Ref.2. Source: ProtInc nuclear inner membraneInferred from electronic annotation. Source: Compara |
| Molecular_function | DNA binding Inferred from electronic annotation. Source: UniProtKB-KW lamin bindingTraceable author statement Ref.2. Source: ProtInc |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] Note: Additional isoforms seem to exist. | ||||||
| Isoform Alpha (identifier: P42166-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Beta (identifier: P42167-1) The sequence of this isoform can be found in the external entry P42167. Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly. | ||||||
| Isoform Gamma (identifier: P42167-2) The sequence of this isoform can be found in the external entry P42167. Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.4 | ||||||||||||||||||||||||||||
| Chain | 2 – 694 | 693 | Lamina-associated polypeptide 2, isoform alpha | PRO_0000017674 | |||||||||||||||||||||||||||
| Peptide | 2 – 50 | 49 | Thymopoietin | PRO_0000017675 | |||||||||||||||||||||||||||
| Peptide | 33 – 37 | 5 | Thymopentin | PRO_0000017676 | |||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||
| Domain | 5 – 48 | 44 | LEM-like | ||||||||||||||||||||||||||||
| Domain | 109 – 153 | 45 | LEM | ||||||||||||||||||||||||||||
| Region | 49 – 108 | 60 | Linker | ||||||||||||||||||||||||||||
| Coiled coil | 558 – 657 | 100 | By similarity | ||||||||||||||||||||||||||||
| Motif | 190 – 196 | 7 | Nuclear localization signal Potential | ||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||
| Modified residue | 57 | 1 | Phosphothreonine Ref.16 | ||||||||||||||||||||||||||||
| Modified residue | 59 | 1 | Phosphoserine Ref.22 | ||||||||||||||||||||||||||||
| Modified residue | 66 | 1 | Phosphoserine Ref.16 Ref.18 | ||||||||||||||||||||||||||||
| Modified residue | 67 | 1 | Phosphoserine Ref.16 Ref.18 | ||||||||||||||||||||||||||||
| Modified residue | 74 | 1 | Phosphothreonine Ref.13 Ref.15 Ref.16 Ref.18 Ref.20 Ref.22 | ||||||||||||||||||||||||||||
| Modified residue | 79 | 1 | Phosphoserine Ref.16 Ref.18 | ||||||||||||||||||||||||||||
| Modified residue | 154 | 1 | Phosphothreonine Ref.18 | ||||||||||||||||||||||||||||
| Modified residue | 156 | 1 | Phosphoserine Ref.20 | ||||||||||||||||||||||||||||
| Modified residue | 160 | 1 | Phosphothreonine Ref.16 Ref.18 Ref.20 | ||||||||||||||||||||||||||||
| Modified residue | 164 | 1 | Phosphothreonine Ref.16 | ||||||||||||||||||||||||||||
| Modified residue | 184 | 1 | Phosphoserine Ref.22 | ||||||||||||||||||||||||||||
| Modified residue | 351 | 1 | Phosphoserine Ref.10 Ref.12 Ref.15 Ref.16 Ref.18 Ref.20 Ref.22 | ||||||||||||||||||||||||||||
| Modified residue | 354 | 1 | Phosphoserine Ref.20 Ref.22 | ||||||||||||||||||||||||||||
| Modified residue | 370 | 1 | Phosphoserine Ref.16 Ref.20 | ||||||||||||||||||||||||||||
| Modified residue | 424 | 1 | Phosphoserine Ref.12 Ref.13 Ref.15 Ref.16 Ref.18 Ref.20 | ||||||||||||||||||||||||||||
| Modified residue | 656 | 1 | N6-acetyllysine Ref.19 | ||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||
| Natural variant | 238 | 1 | L → R. Corresponds to variant rs35998138 [ dbSNP | Ensembl ]. | VAR_049773 | |||||||||||||||||||||||||||
| Natural variant | 293 | 1 | S → A. Corresponds to variant rs35645287 [ dbSNP | Ensembl ]. | VAR_049774 | |||||||||||||||||||||||||||
| Natural variant | 317 | 1 | T → S. Corresponds to variant rs35969221 [ dbSNP | Ensembl ]. | VAR_049775 | |||||||||||||||||||||||||||
| Natural variant | 416 | 1 | K → E. Corresponds to variant rs11838270 [ dbSNP | Ensembl ]. | VAR_049776 | |||||||||||||||||||||||||||
| Natural variant | 478 | 1 | K → N. Corresponds to variant rs35761089 [ dbSNP | Ensembl ]. | VAR_049777 | |||||||||||||||||||||||||||
| Natural variant | 599 | 1 | Q → E. Ref.2 Corresponds to variant rs17459334 [ dbSNP | Ensembl ]. | VAR_005635 | |||||||||||||||||||||||||||
| Natural variant | 690 | 1 | R → C in CMD1T; affects the interaction with LMNA. Ref.25 Corresponds to variant rs17028450 [ dbSNP | Ensembl ]. | VAR_049778 | |||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||
| Beta strand | 8 – 11 | 4 | |||||||||||||||||||||||||||||
| Helix | 13 – 22 | 10 | |||||||||||||||||||||||||||||
| Beta strand | 29 – 31 | 3 | |||||||||||||||||||||||||||||
| Helix | 34 – 39 | 6 | |||||||||||||||||||||||||||||
| Turn | 40 – 42 | 3 | |||||||||||||||||||||||||||||
| Beta strand | 43 – 45 | 3 | |||||||||||||||||||||||||||||
| Turn | 46 – 48 | 3 | |||||||||||||||||||||||||||||
| Beta strand | 113 – 115 | 3 | |||||||||||||||||||||||||||||
| Helix | 117 – 122 | 6 | |||||||||||||||||||||||||||||
| Beta strand | 123 – 125 | 3 | |||||||||||||||||||||||||||||
| Turn | 126 – 128 | 3 | |||||||||||||||||||||||||||||
| Beta strand | 136 – 138 | 3 | |||||||||||||||||||||||||||||
| Helix | 139 – 145 | 7 | |||||||||||||||||||||||||||||
| Helix | 147 – 152 | 6 | |||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Three distinct human thymopoietins are derived from alternatively spliced mRNAs." Harris C.A., Andryuk P.J., Cline S.W., Chan H.K., Natarajan A., Siekierka J.J., Goldstein G. Proc. Natl. Acad. Sci. U.S.A. 91:6283-6287(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA; BETA AND GAMMA). Tissue: Thymus. |
| [2] | "Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat lamin-associated polypeptide 2." Harris C.A., Andryuk P.J., Cline S.W., Siekierka J.J., Goldstein G. Genomics 28:198-205(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS ALPHA; BETA AND GAMMA), VARIANT GLU-599. |
| [3] | "A new thymopoietin precursor gene from human thymus." Hara H., Hayashi K., Ohta K., Itoh N., Ohta M. Biochem. Mol. Biol. Int. 34:927-933(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-526. Tissue: Thymus. |
| [4] | Bienvenut W.V., Vousden K.H., Lukashchuk N. Submitted (MAR-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-13; 127-139; 254-264; 417-427 AND 526-535, CLEAVAGE OF INITIATOR METHIONINE, MASS SPECTROMETRY. Tissue: Lung carcinoma. |
| [5] | "Isolation and complete amino acid sequence of human thymopoietin and splenin." Audhya T., Schlesinger D.H., Goldstein G. Proc. Natl. Acad. Sci. U.S.A. 84:3545-3549(1987) [PubMed] [Europe PMC] [Abstract] Cited for: PARTIAL PROTEIN SEQUENCE. |
| [6] | Erratum Goldstein G., Schlesinger D.H., Audhya T. Proc. Natl. Acad. Sci. U.S.A. 91:6249-6249(1994) [PubMed] [Europe PMC] [Abstract] Cited for: RETRACTION. |
| [7] | "Detergent-salt resistance of LAP2alpha in interphase nuclei and phosphorylation-dependent association with chromosomes early in nuclear assembly implies functions in nuclear structure dynamics." Dechat T., Gotzmann J., Stockinger A., Harris C.A., Talle M.A., Siekierka J.J., Foisner R. EMBO J. 17:4887-4902(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CHROMOSOMES, PHOSPHORYLATION. |
| [8] | "Lamina-associated polypeptide 2alpha binds intranuclear A-type lamins." Dechat T., Korbei B., Vaughan O.A., Vlcek S., Hutchison C.J., Foisner R. J. Cell Sci. 113:3473-3484(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH LMNA. |
| [9] | "Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein." Markiewicz E., Dechat T., Foisner R., Quinlan R.A., Hutchison C.J. Mol. Biol. Cell 13:4401-4413(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH LMNA AND RB1. |
| [10] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Prostate cancer. |
| [12] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351 AND SER-424, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-74 AND SER-424, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: T-cell. |
| [15] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-74; SER-351 AND SER-424, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-57; SER-66; SER-67; THR-74; SER-79; THR-160; THR-164; SER-351; SER-370 AND SER-424, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Liver. |
| [18] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-67; THR-74; SER-79; THR-154; THR-160; SER-351 AND SER-424, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [19] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-656, MASS SPECTROMETRY. |
| [20] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-74; SER-156; THR-160; SER-351; SER-354; SER-370 AND SER-424, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [21] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [22] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59; THR-74; SER-184; SER-351 AND SER-354, MASS SPECTROMETRY. |
| [23] | "Solution structure of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one binds BAF and the other binds DNA." Cai M., Huang Y., Ghirlando R., Wilson K.L., Craigie R., Clore G.M. EMBO J. 20:4399-4407(2001) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 1-169. |
| [24] | "Structural characterization of the LEM motif common to three human inner nuclear membrane proteins." Laguri C., Gilquin B., Wolff N., Romi-Lebrun R., Courchay K., Callebaut I., Worman H.J., Zinn-Justin S. Structure 9:503-511(2001) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 1-57 AND 103-159. |
| [25] | "Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy." Taylor M.R., Slavov D., Gajewski A., Vlcek S., Ku L., Fain P.R., Carniel E., Di Lenarda A., Sinagra G., Boucek M.M., Cavanaugh J., Graw S.L., Ruegg P., Feiger J., Zhu X., Ferguson D.A., Bristow M.R., Gotzmann J., Foisner R., Mestroni L. Hum. Mutat. 26:566-574(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT CMD1T CYS-690, CHARACTERIZATION OF VARIANT CMD1T CYS-690. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U09086 mRNA. Translation: AAB60329.1. U18270 U18268 Genomic DNA. Translation: AAB60433.1.S76736 mRNA. Translation: AAB33958.1. | ||||||||||||||||||||||||
| IPI | IPI00216230. | ||||||||||||||||||||||||
| PIR | G01161. | ||||||||||||||||||||||||
| RefSeq | NP_003267.1. NM_003276.2. | ||||||||||||||||||||||||
| UniGene | Hs.11355. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P42166. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | P42166. 14 interactions. | ||||||||||||||||||||||||
| MINT | MINT-2863664. | ||||||||||||||||||||||||
| STRING | 9606.ENSP00000266732. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 1174689. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | P42166. | ||||||||||||||||||||||||
| PeptideAtlas | P42166. | ||||||||||||||||||||||||
| PRIDE | P42166. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| DNASU | 7112. | ||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000266732; ENSP00000266732; ENSG00000120802. | ||||||||||||||||||||||||
| GeneID | 7112. | ||||||||||||||||||||||||
| KEGG | hsa:7112. | ||||||||||||||||||||||||
| UCSC | uc001tfh.2. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 7112. | ||||||||||||||||||||||||
| GeneCards | GC12P098909. | ||||||||||||||||||||||||
| HGNC | HGNC:11875. TMPO. | ||||||||||||||||||||||||
| HPA | CAB009847. | ||||||||||||||||||||||||
| MIM | 188380. gene. 613740. phenotype. | ||||||||||||||||||||||||
| neXtProt | NX_P42166. | ||||||||||||||||||||||||
| Orphanet | 154. Familial isolated dilated cardiomyopathy. | ||||||||||||||||||||||||
| PharmGKB | PA36576. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | NOG87051. | ||||||||||||||||||||||||
| HOGENOM | HOG000060228. | ||||||||||||||||||||||||
| HOVERGEN | HBG081890. | ||||||||||||||||||||||||
| InParanoid | P42166. | ||||||||||||||||||||||||
| OrthoDB | EOG428214. | ||||||||||||||||||||||||
| PhylomeDB | P42166. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P42166. | ||||||||||||||||||||||||
| Bgee | P42166. | ||||||||||||||||||||||||
| CleanEx | HS_TMPO. | ||||||||||||||||||||||||
| Genevestigator | P42166. | ||||||||||||||||||||||||
| GermOnline | ENSG00000120802. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 1.10.720.40. 2 hits. | ||||||||||||||||||||||||
| InterPro | IPR021623. LAP2alpha. IPR013146. LEM-like_dom. IPR011015. LEM/LEM-like_dom. IPR003887. LEM_dom. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF11560. LAP2alpha. 1 hit. PF03020. LEM. 1 hit. PF08198. Thymopoietin. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SMART | SM00540. LEM. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SUPFAM | SSF63451. LEM_like. 2 hits. | ||||||||||||||||||||||||
| PROSITE | PS50954. LEM. 1 hit. PS50955. LEM_LIKE. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| ChiTaRS | TMPO. human. | ||||||||||||||||||||||||
| EvolutionaryTrace | P42166. | ||||||||||||||||||||||||
| GenomeRNAi | 7112. | ||||||||||||||||||||||||
| NextBio | 27839. | ||||||||||||||||||||||||
| PMAP-CutDB | P42166. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | LAP2A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P42166 Secondary accession number(s): P08918 Q16295 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
